Vera Hirsh
- Oncology top 0.05%
- Pulmonary and Respiratory Medicine top 0.02%
- Molecular Biology top 1%
- Cancer Research top 0.5%
- Radiology, Nuclear Medicine and Imaging top 0.5%
- Co-authors
- Frances A. ShepherdTony MokJames Chih‐Hsin YangLesley SeymourAndrea BezjakTudor–Eliade CiuleanuSumitra ThongprasertEng Huat Tan
- Topics
- Lung Cancer Treatments and Mutations (153 papers)Lung Cancer Research Studies (65 papers)Colorectal Cancer Treatments and Studies (49 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Vera Hirsh
195 papers receiving 19.2k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Oncology 14.7k
- Pulmonary and Respiratory Medicine 14.2k
- Molecular Biology 4.9k
- Cancer Research 2.8k
- Radiology, Nuclear Medicine and Imaging 1.5k
Countries citing papers authored by Vera Hirsh
This map shows the geographic impact of Vera Hirsh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vera Hirsh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vera Hirsh more than expected).
Fields of papers citing papers by Vera Hirsh
This network shows the impact of papers produced by Vera Hirsh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vera Hirsh. The network helps show where Vera Hirsh may publish in the future.
Co-authorship network of co-authors of Vera Hirsh
This figure shows the co-authorship network connecting the top 25 collaborators of Vera Hirsh. A scholar is included among the top collaborators of Vera Hirsh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vera Hirsh. Vera Hirsh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 16 | |
| 2 | 1 | |
| 3 | 5 | |
| 4 | First-line afatinib versus chemotherapy in patients with non-small cell lung cancer and common epidermal growth factor receptor gene mutations and brain metastases | 1 |
| 5 | Afatinib (A) vs gefitinib (G) in patients (pts) with EGFR mutation-positive (EGFRm+) non-small-cell lung cancer (NSCLC): overall survival (OS) data from the phase IIb trial LUX-Lung 7 (LL7) (Conference Abstract) | 1 |
| 6 | 2 | |
| 7 | 4 | |
| 8 | 0 | |
| 9 | 9 | |
| 10 | 1 | |
| 11 | 81 | |
| 12 | 6 | |
| 13 | Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutationsbreakdown → | 2461 |
| 14 | 57 | |
| 15 | 1 | |
| 16 | 92 | |
| 17 | 17 | |
| 18 | 1 | |
| 19 | 6 | |
| 20 | 212 |
About Vera Hirsh
Vera Hirsh is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hepatology, having authored 197 papers that have together received 19.7k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (153 papers), Lung Cancer Research Studies (65 papers) and Colorectal Cancer Treatments and Studies (49 papers). The work is most often cited by research in Oncology (14.7k citations), Pulmonary and Respiratory Medicine (14.2k citations) and Cancer Research (2.8k citations). Vera Hirsh has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Frances A. Shepherd, Tony Mok, James Chih‐Hsin Yang, Lesley Seymour, Andrea Bezjak, Tudor–Eliade Ciuleanu, Sumitra Thongprasert, Eng Huat Tan, Michael Smylie and José Rodrigues Pereira. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.